ArticleJournal of translational medicine2021

Use of proteomics to identify mechanisms of hepatocellular carcinoma with the CYP2D6*10 polymorphism and identification of ANGPTL6 as a new diagnostic and prognostic biomarker.

Guiming Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.